Alison Yeomans

539 total citations
20 papers, 339 citations indexed

About

Alison Yeomans is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Alison Yeomans has authored 20 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Genetics and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Alison Yeomans's work include Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (7 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Alison Yeomans is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Lymphoma Diagnosis and Treatment (7 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Alison Yeomans collaborates with scholars based in United Kingdom, Italy and United States. Alison Yeomans's co-authors include Samantha Lane, Saad Shakir, Graham Packham, Francesco Forconi, Andrew J. Steele, Freda K. Stevenson, Stephen M. Thirdborough, Adam J. Linley, Mark J. Coldwell and Simon D. Wagner and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Cancer Research.

In The Last Decade

Alison Yeomans

20 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Yeomans United Kingdom 10 151 137 89 72 56 20 339
Lorenzo Iovino United States 10 71 0.5× 79 0.6× 70 0.8× 86 1.2× 36 0.6× 38 317
Zhengrong Mao China 9 104 0.7× 155 1.1× 175 2.0× 89 1.2× 27 0.5× 16 385
Barbora Ravčuková Czechia 12 82 0.5× 48 0.4× 43 0.5× 98 1.4× 8 0.1× 22 299
Masakazu Sawanobori Japan 9 97 0.6× 38 0.3× 44 0.5× 80 1.1× 17 0.3× 17 357
Marco Fossati Italy 9 46 0.3× 36 0.3× 17 0.2× 92 1.3× 17 0.3× 22 264
Muhammed Iraqi Israel 11 44 0.3× 25 0.2× 24 0.3× 61 0.8× 17 0.3× 17 268
Yuqing Miao China 8 70 0.5× 24 0.2× 44 0.5× 53 0.7× 25 0.4× 22 228
Daigo Akahane Japan 10 85 0.6× 53 0.4× 28 0.3× 26 0.4× 13 0.2× 46 277
Kory J. Engelke United States 10 202 1.3× 55 0.4× 17 0.2× 93 1.3× 22 0.4× 16 476

Countries citing papers authored by Alison Yeomans

Since Specialization
Citations

This map shows the geographic impact of Alison Yeomans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Yeomans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Yeomans more than expected).

Fields of papers citing papers by Alison Yeomans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Yeomans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Yeomans. The network helps show where Alison Yeomans may publish in the future.

Co-authorship network of co-authors of Alison Yeomans

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Yeomans. A scholar is included among the top collaborators of Alison Yeomans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Yeomans. Alison Yeomans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roy, Debabrata, et al.. (2025). Safety and effectiveness of the anti‐amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer's disease: The pharmacovigilance perspective. British Journal of Clinical Pharmacology. 91(5). 1352–1360. 3 indexed citations
2.
Platt, Robert W., et al.. (2024). The International Working Group on New Developments in Pharmacovigilance: Advancing Methods and Communication in Pharmacovigilance. Clinical Therapeutics. 46(7). 565–569. 1 indexed citations
3.
Luxi, Nicoletta, Pasquale De Nardo, Alessia Savoldi, et al.. (2023). Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy. BioDrugs. 37(5). 675–684. 2 indexed citations
4.
5.
Lane, Samantha, Alison Yeomans, & Saad Shakir. (2022). Systematic review of spontaneous reports of myocarditis and pericarditis in transplant recipients and immunocompromised patients following COVID-19 mRNA vaccination. BMJ Open. 12(7). e060425–e060425. 12 indexed citations
6.
Coldwell, Mark J., Freda K. Stevenson, Francesco Forconi, et al.. (2022). B-cell receptor signaling induces proteasomal degradation of PDCD4 via MEK1/2 and mTORC1 in malignant B cells. Cellular Signalling. 94. 110311–110311. 4 indexed citations
7.
Stevenson, Freda K., Francesco Forconi, Andrew J. Steele, et al.. (2021). Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells. Cellular and Molecular Life Sciences. 78(17-18). 6337–6349. 22 indexed citations
8.
9.
Loxham, Matthew, Jeongmin Woo, Akul Singhania, et al.. (2020). Upregulation of epithelial metallothioneins by metal-rich ultrafine particulate matter from an underground railway. Metallomics. 12(7). 1070–1082. 9 indexed citations
10.
Yeomans, Alison, et al.. (2020). Targeted inhibition of mRNA translation initiation factors as a novel therapeutic strategy for mature B-cell neoplasms. SHILAP Revista de lepidopterología. 1(1). 3–25. 7 indexed citations
11.
Arruga, Francesca, Nicoletta Vitale, Tiziana Vaisitti, et al.. (2019). Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter’s syndrome: therapeutic implications. Leukemia. 34(2). 462–477. 23 indexed citations
12.
Heward, James A., Annalisa D’Avola, Alison Yeomans, et al.. (2019). S844 KDM5 INHIBITION OFFERS A NOVEL THERAPEUTIC STRATEGY FOR THE TREATMENT OF KMT2D MUTANT LYMPHOMAS. HemaSphere. 3(S1). 376–377. 1 indexed citations
13.
Tillotson, Joseph, Alison Yeomans, Carlos Jiménez‐Romero, et al.. (2018). Target-Based Screening against eIF4A1 Reveals the Marine Natural Product Elatol as a Novel Inhibitor of Translation Initiation with In Vivo Antitumor Activity. Clinical Cancer Research. 24(17). 4256–4270. 36 indexed citations
14.
Arruga, Francesca, Alison Yeomans, Annalisa D’Avola, et al.. (2018). NOTCH1 Stabilization By PEST Mutations Enhances IgM-Mediated Activity in Chronic Lymphocytic Leukemia. Blood. 132(Supplement 1). 1832–1832. 1 indexed citations
15.
Papadakis, Emmanouil, Alison Yeomans, Stephen A. Beers, et al.. (2016). A combination of trastuzumab and BAG-1 inhibition synergistically targets HER2 positive breast cancer cells. Oncotarget. 7(14). 18851–18864. 11 indexed citations
16.
Yeomans, Alison, Breeze E. Cavell, Beatriz Valle‐Argos, et al.. (2016). PEITC-mediated inhibition of mRNA translation is associated with both inhibition of mTORC1 and increased eIF2α phosphorylation in established cell lines and primary human leukemia cells. Oncotarget. 7(46). 74807–74819. 10 indexed citations
17.
Sbarrato, Thomas, Tuija Pöyry, Kirsti Hill, et al.. (2016). A ribosome-related signature in peripheral blood CLL B cells is linked to reduced survival following treatment. Cell Death and Disease. 7(6). e2249–e2249. 25 indexed citations
18.
Aguilar-Hernández, Montserrat, Matthew D. Blunt, Rachel Dobson, et al.. (2016). IL-4 enhances expression and function of surface IgM in CLL cells. Blood. 127(24). 3015–3025. 69 indexed citations
19.
D’Avola, Annalisa, Alison Yeomans, Matthew Rose‐Zerilli, et al.. (2016). Global and MYC-Specific Translation Is Enhanced in Activated Chronic Lymphocytic Leukemia Cells Carrying NOTCH1 C.7541_7542delct Mutations. Blood. 128(22). 970–970. 2 indexed citations
20.
Yeomans, Alison, Stephen M. Thirdborough, Beatriz Valle‐Argos, et al.. (2015). Engagement of the B-cell receptor of chronic lymphocytic leukemia cells drives global and MYC-specific mRNA translation. Blood. 127(4). 449–457. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lorenzo Iovino Breakdown of academic impact, for papers by Zhengrong Mao Breakdown of academic impact, for papers by Barbora Ravčuková Breakdown of academic impact, for papers by Masakazu Sawanobori Breakdown of academic impact, for papers by Marco Fossati Breakdown of academic impact, for papers by Muhammed Iraqi Breakdown of academic impact, for papers by Yuqing Miao Breakdown of academic impact, for papers by Daigo Akahane Breakdown of academic impact, for papers by Kory J. Engelke
Rankless by CCL
2026